Invesco Biotechnology & Genome ETF
PBE
#2031
ETF rank
ยฃ0.19 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
ยฃ59.62
Share price
-0.82%
Change (1 day)
11.67%
Change (1 year)

Invesco Biotechnology & Genome ETF - Holdings

Etf holdings as of February 10, 2026

Number of holdings: 31

Full holdings list

Weight %NameTickerShares Held
6.02%
Gilead Sciences IncGILD107276
5.59%
Amgen IncAMGN40199
5.48%
Biogen IncBIIB76001
5.08%
United Therapeutics CorpUTHR28161
5.08%
Regeneron Pharmaceuticals IncREGN17649
4.86%
Illumina IncILMN106688
4.83%
Incyte CorpINCY126491
4.04%
Amicus Therapeutics IncFOLD741162
3.81%
Alnylam Pharmaceuticals IncALNY30948
3.18%
MannKind CorpMNKD1428868
3.11%
Royalty Pharma PLCRPRX184405
3.03%
Halozyme Therapeutics IncHALO99056
3.03%
QIAGEN NVQGEN155441.3786
3.01%
BioMarin Pharmaceutical IncBMRN132074
3.00%
Ionis Pharmaceuticals IncIONS93353
2.89%
Catalyst Pharmaceuticals IncCPRX311787
2.87%
Collegium Pharmaceutical IncCOLL160836
2.85%
Bio-Techne CorpTECH115453
2.84%
Exelixis IncEXEL173494
2.72%
Neurocrine Biosciences IncNBIX51895
2.68%
BioCryst Pharmaceuticals IncBCRX1073219
2.67%
Protagonist Therapeutics IncPTGX83592
2.66%
ACADIA Pharmaceuticals IncACAD306699
2.56%
Vericel CorpVCEL188531
2.54%
TG Therapeutics IncTGTX228851
2.53%
PTC Therapeutics IncPTCT91821
2.39%
Repligen CorpRGEN43826
2.28%
Madrigal Pharmaceuticals IncMDGL12469
2.22%
Veracyte IncVCYT156961
0.15%
Invesco Government & Agency PortfolioAGPXX380750.16
0.00%
CASH & EQUIVALENTSUSD6772.55